Source: Quebec Precious Metals.
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Quebec Precious Metals (QPM) has signed an agreement with ALS GoldSpot Discoveries to conduct a detailed lithium targeting study
  • The study is planned for all of its exploration projects in the Eeyou Istchee James Bay territory of Quebec
  • The results are expected in summer 2023, after which QPM plans to undertake lithium-specific exploration programs
  • QPM’s Elmer East project is located close to three significant lithium deposits being developed by Allkem, Critical Elements Lithium, and Investissement Québec and Livent Corporation
  • Quebec Precious Metals (QPM) opened trading at $0.09 per share

Quebec Precious Metals (QPM) has hired ALS GoldSpot Discoveries to conduct a lithium targeting study.

All of the company’s exploration projects in the Eeyou Istchee James Bay territory in Quebec will fall under the study’s purview.

The area is highly prospective for lithium and QPM is aiming to test the potential of pegmatite occurrences in the region. The company is looking to generate targets using geoscience expertise, ALS GoldSpot’s data analytics workflows, and AI and machine learning algorithms.

The results of the study are expected in summer 2023, after which QPM intends to undertake lithium-specific exploration programs.

QPM’s Elmer East project is located close to three significant lithium deposits being developed by Allkem, Critical Elements Lithium, and Investissement Québec and Livent Corporation.

Quebec Precious Metals is an exploration company primarily focused on advancing its Sakami gold project, located in Eeyou Istchee James Bay territory in Quebec, near Newmont Corporation’s Eleonore gold mine. QPM also owns 12 million shares in Idaho Champion.

Quebec Precious Metals (QPM) opened trading at $0.09 per share.


More From The Market Herald

" Africa Oil holding renews key oil mining license

Africa Oil holding Prime Oil & Gas has renewed oil mining license (OML) 130 in Nigeria for 20 years.
Neuralink - Founder, Elon Musk.

" Neuralink brain chips approved for human trials

Elon Musk’s Neuralink, a brain implant firm, has received regulatory approval for U.S. human trials.

" Next-level payment platform launches worldwide

RevoluGROUP Canada (TSXV:REVO) has launched RevoluPOS, a worldwide credit and debit card processing platform.